These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28296286)

  • 41. Bio-inspired nanomedicine strategies for artificial blood components.
    Sen Gupta A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Status and trends in the development of clinical diagnostic agents.
    Opacic T; Paefgen V; Lammers T; Kiessling F
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 27800665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photoactivated drug delivery and bioimaging.
    Yang Y; Mu J; Xing B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in applying nanotechnologies for cancer immunotherapy.
    Mahjub R; Jatana S; Lee SE; Qin Z; Pauli G; Soleimani M; Madadi S; Li SD
    J Control Release; 2018 Oct; 288():239-263. PubMed ID: 30223043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics.
    Hong E; Dobrovolskaia MA
    Adv Drug Deliv Rev; 2019 Feb; 141():3-22. PubMed ID: 29339144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Instigation of the epoch of nanovaccines in cancer immunotherapy.
    Shah S; Famta P; Tiwari V; Kotha AK; Kashikar R; Chougule MB; Chung YH; Steinmetz NF; Uddin M; Singh SB; Srivastava S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1870. PubMed ID: 36410742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer immunotherapy from biology to nanomedicine.
    Abdelbaky SB; Ibrahim MT; Samy H; Mohamed M; Mohamed H; Mustafa M; Abdelaziz MM; Forrest ML; Khalil IA
    J Control Release; 2021 Aug; 336():410-432. PubMed ID: 34171445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging nanotechnologies for cancer immunotherapy.
    Shukla S; Steinmetz NF
    Exp Biol Med (Maywood); 2016 May; 241(10):1116-26. PubMed ID: 27190253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer Nanomedicine: Lessons for Immuno-Oncology.
    Sengupta S
    Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
    Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk.
    Halappanavar S; Vogel U; Wallin H; Yauk CL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jan; 10(1):. PubMed ID: 28294555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.
    Selby LI; Cortez-Jugo CM; Such GK; Johnston APR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28160452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracellular imaging of quantum dots, gold, and iron oxide nanoparticles with associated endocytic pathways.
    Chen D; Monteiro-Riviere NA; Zhang LW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27418010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer nanomedicine: from drug delivery to imaging.
    Chow EK; Ho D
    Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery.
    Jin Q; Liu Z; Chen Q
    J Control Release; 2021 Jan; 329():882-893. PubMed ID: 33053396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
    Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
    Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle.
    Bradbury MS; Pauliah M; Zanzonico P; Wiesner U; Patel S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):535-53. PubMed ID: 26663853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in aliphatic polyesters for drug delivery applications.
    Washington KE; Kularatne RN; Karmegam V; Biewer MC; Stefan MC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 27910243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Label-free detection and manipulation of single biological nanoparticles.
    DeSantis MC; Cheng W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):717-29. PubMed ID: 26846164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.